𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleen

✍ Scribed by Ronald B. Herberman; John Hiserodt; Nicola Vujanovic; Charles Balch; Eva Lotzova; Reinder Bolhuis; Sidney Golub; Lewis L. Lanier; Joseph H. Phillips; Carlo Riccardi; Jerome Ritz; Angela Santoni; Reinholdt E. Schmidt; Atsushi Uchida

Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
589 KB
Volume
8
Category
Article
ISSN
0167-5699

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Lymphokine-activated killer cell and nat
Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis
✍ Thomas V. Kantor; Theresa L. Whiteside; Diana Friberg; Robert B. Buckingham; Tho πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 499 KB πŸ‘ 2 views

Objective. To determine the ability of T lymphocytes and natural killer (NK) cells from patients with systemic sclerosis (SSc) to respond to cytokines and to generate immune effector cells. Methods. The numbers and percentages of peripheral blood T and NK cells were examined by 2-color flow cytometr

Lymphokine-activated killer cell activit
Lymphokine-activated killer cell activity of peripheral blood, spleen, regional lymph node, and tumor infiltrating lymphocytes in gastric cancer patients
✍ Nobuya Karimine; Shigeru Nanbara; Shinya Arinaga; Tsukasa Asoh; Hiroaki Ueo; Tsu πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 661 KB

Lymphokine-activated killer (LAK) cell activity of peripheral blood mononuclear cells (PBM), spleen cells (SPC), regional lymph node cells (LNC), and tumor-infiltrating lymphocytes (TIL), induced by activation with interleukin 2 (IL 2) for 4 days, was evaluated in patients with gastric carcinoma. TI

Defective function of lymphokine-activat
Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma
✍ Toshiji Saibara; Saburo Onishi; Hiroshi Sakaeda; Yasutake Yamamoto πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 608 KB

Lymphokine-activated killer activity and natural killer activity in hepatocellular carcinoma patients were d. Maximum lymphokine-activated killer activity was induced at 3 to 6 days of incubation, and lymphokine-activated killer activity tended to increase in a manner dose dependent of recombinant i